Production of a Trioxacarcin Analogue by Engineering of Its Biosynthetic Pathway

Li-Hua Qi,Mei Zhang,Hai-Xue Pan,Xiao-Dong Chen,Gong-Li Tang
DOI: https://doi.org/10.6023/cjoc201403032
2014-01-01
Abstract:Trioxacarcins, derived from streptomyces, are aromatic polyketide natural products with antitumor activity. The production of trioxacarcins was improved significantly by optimizing the fermentation and purification processes. The biosyn-thetic pathway of trioxacarcins was changed by inactivating an acyltransferase (Trx49) gene in the trioxacarcin cluster, and an analogue compound 1 lacking the O-acetyl group of sugar on C-4 was obtained. The influence of the O-acetyl group on bio-logical activity of trioxacarcins was investigated by in vitro cytotoxicity test. Compared with trioxacarcin A, the activity of compound 1 decreases to some extent but still persists an excellent anti-tumor activity level with IC50 value of 4.86 nmol?L-1.
What problem does this paper attempt to address?